๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bcr-Abl Kinase Domain Mutations and the Unsettled Problem of Bcr-AblT315I: Looking into the Future of Controlling Drug Resistance in Chronic Myeloid Leukemia

โœ Scribed by O'Hare, Thomas; Eide, Christopher A.; Deininger, Michael W.


Book ID
119935986
Publisher
CIG Media Group, LP.
Year
2007
Tongue
English
Weight
362 KB
Volume
7
Category
Article
ISSN
1557-9190

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Practical advice for determining the rol
โœ Elias Jabbour; Susan Branford; Giuseppe Saglio; Dan Jones; Jorge E. Cortes; Hago ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 1 views

## Abstract Data demonstrating the superiority of nilotinib over imatinib in the frontline treatment of chronic myeloid leukemia (CML) and ongoing studies with dasatinib and bosutinib are rapidly changing the treatment landscape for CML. In this review, the authors discuss currently available thera